Kymera Therapeutics Inc at Citi Global Healthcare Conference Transcript
()-
All right. So welcome to the second day of the Citi Global Healthcare Conference. So I'm Geoff Meacham, I'm the senior biopharma analyst, and my team is here in front, too. So we're thrilled today to have Kymera Therapeutics. We have Bruce Jacobs, the CFO. We have Jared Gollob. So welcome, guys. Good to have you. We got some questions here, but maybe you want to give sort of just a real quick like kind of a couple of minute overview, and then we can get into some of the detail.
Sure, Geoff. Thanks so much for having us. It's always great to be at your conferences. So it's been a busy and active year for Kymera. As I think most of you hopefully know by this point, we're one of the leaders in the targeted protein degradation field.
We're actually coming up upon the 10-year anniversary of Kymera's founding, which will be next May. And I think it's amazing from where I sit to look at how the company has
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
